Wouldn't it be great to be able to predict who will develop MS? A new diagnostic test based on mutated antibody genes in B cells can identify patients with clinically isolated syndrome who are at high risk of converting to relapsing MS.
A new strategy helps determine whether change over time on commonly used neuropsychological tests reflects reliable improvement or decline in individuals with MS
Laurie Barclay, M.D.
A new analytic strategy may help determine whether change over time on commonly used neuropsychological tests reflects...